The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
4460.06
COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB VS. TUMOR NECROSIS FACTOR ANTAGONISTS IN OLDER ADULTS WITH IBD: A NATIONWIDE COHORT STUDY
Date
May 23, 2022
Explore related products in the following collection: